Funder
Japan Blood Products Organization
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost. 2009;101:806–12.
2. Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010;126:373–8. https://doi.org/10.1016/j.thromres.2010.08.010.
3. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311–5. https://doi.org/10.1016/j.ajog.2005.11.008.
4. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171–96. https://doi.org/10.1111/j.1365-2141.2005.05847.x.
5. Royal College of Obstetricians and Gynaecologists (RCOG). Reducing the risk of venous thromboembolism during pregnancy and the puerperium. RCOG Green-top Guideline No. 37a. 2015. URL; https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf. Accessed 7 Dec 2022.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献